Join
Live feed
·
SECFilingvia Quantisnow
Aeglea BioTherapeutics Inc. logo

Aeglea BioTherapeutics Inc. filed SEC Form 8-K: Costs Associated with Exit or Disposal Activities, Leadership Update, Other Events, Financial Statements and Exhibits

ByQuantisnow·Wall Street's wire, on your screen.
AGLE· Aeglea BioTherapeutics Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track AGLE (Aeglea BioTherapeutics Inc.) and more on Quantisnow.

Aeglea BioTherapeutics Inc. filed SEC Form 8-K: Costs Associated with Exit or Disposal Activities, Leadership Update, Other Events, Financial Statements and Exhibits | Quantisnow